News | September 20, 2024
Pharmaceutical sector set for 8-10% revenue growth this fiscal: CRISIL
Stable profits, low leverage to keep credit profiles comfortable
Stable profits, low leverage to keep credit profiles comfortable
Dhiraj brings 20+ years of extensive executive-level financial expertise across various industries including Pharma, Media, Retail, and FMCG
The drugmaker's net profit slipped 26 per cent on-year to Rs 143.8 crore
EBITDA at Rs. 250 crore, up 47% YoY, with 35% EBITDA margin
Dr. Roopal Thakkar joined Abbott/AbbVie in 2003 as part of the Physician Development Program
Aims to become a leading global partner for botanical extracts and natural actives in the beauty and personal care market
Bolsters Merck Animal Health’s position in the aqua industry with comprehensive approach to ensure fish health, welfare and sustainability in aquaculture, conservation and fisheries
Acquisition includes HPN328, an investigational delta-like ligand 3 (DLL3) targeting T-cell engager being evaluated in certain patients with small cell lung cancer and neuroendocrine tumors
His M&A background and experience with successful private-equity-backed companies will benefit the company’s growth and diversification strategy
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Subscribe To Our Newsletter & Stay Updated
